Would the Trump administration's recently proposed drug pricing reforms hurt the biotech sector more than pharma? Seeking ...

Unlike Trump's first term, his proposed "most favored nation" policy, tying U.S. drug prices to the lowest prices paid by ...

Donald Trump has signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines ...

Health policy experts said it is still unclear how much prices will go down, which medicines will be impacted and whether the ...

U.S. President Donald Trump holds an executive order on prescription drug pricing next to U.S. Health and Human Services (HHS ...

President Donald Trump is attempting to slash drug prices for Americans by more closely aligning their costs to lower prices paid abroad, renewing and expanding upon a failed push from his first term.

The order is a blow to the pharmaceutical industry, which is already bracing for Trump’s planned tariffs on prescription ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...

Amid the ongoing uncertainty about tariffs, muted earnings season, and recession concerns, the stock market has remained ...